Coexpression cluster: Cluster_451 (HCCA Clusters (HRR 50 & PCC 0.5))

View as:



Average Expression Profile

Enriched GO Terms (corrected p-value < 0.05) (download table)
ID Label % in cluster Enrichment log2 p-value Corrected p-value
GO:0045661 regulation of myoblast differentiation 50.0% (1/2) 10.55 0.000665 0.01025
GO:0060298 positive regulation of sarcomere organization 50.0% (1/2) 10.55 0.000665 0.01025
GO:2001014 regulation of skeletal muscle cell differentiation 50.0% (1/2) 10.55 0.000665 0.01025
GO:0010831 positive regulation of myotube differentiation 50.0% (1/2) 10.8 0.000563 0.011342
GO:1905868 regulation of 3'-UTR-mediated mRNA stabilization 50.0% (1/2) 10.8 0.000563 0.011342
GO:1905870 positive regulation of 3'-UTR-mediated mRNA stabilization 50.0% (1/2) 10.8 0.000563 0.011342
GO:1990715 mRNA CDS binding 50.0% (1/2) 10.8 0.000563 0.011342
GO:0007319 negative regulation of oskar mRNA translation 50.0% (1/2) 10.08 0.000921 0.011488
GO:0046011 regulation of oskar mRNA translation 50.0% (1/2) 10.08 0.000921 0.011488
GO:0060297 regulation of sarcomere organization 50.0% (1/2) 10.08 0.000921 0.011488
GO:0060485 mesenchyme development 50.0% (1/2) 10.67 0.000614 0.011489
GO:0001947 heart looping 50.0% (1/2) 9.13 0.00179 0.011725
GO:0003143 embryonic heart tube morphogenesis 50.0% (1/2) 9.13 0.00179 0.011725
GO:0035282 segmentation 50.0% (1/2) 9.13 0.00179 0.011725
GO:0031571 mitotic G1 DNA damage checkpoint signaling 50.0% (1/2) 9.08 0.001841 0.011766
GO:0001756 somitogenesis 50.0% (1/2) 9.8 0.001125 0.011794
GO:0097157 pre-mRNA intronic binding 50.0% (1/2) 9.8 0.001125 0.011794
GO:0044819 mitotic G1/S transition checkpoint signaling 50.0% (1/2) 9.04 0.001892 0.011804
GO:0010830 regulation of myotube differentiation 50.0% (1/2) 9.67 0.001228 0.011913
GO:0061158 3'-UTR-mediated mRNA destabilization 50.0% (1/2) 9.67 0.001228 0.011913
GO:0048702 embryonic neurocranium morphogenesis 50.0% (1/2) 10.25 0.000819 0.011914
GO:0051149 positive regulation of muscle cell differentiation 50.0% (1/2) 9.21 0.001688 0.011951
GO:1990825 sequence-specific mRNA binding 50.0% (1/2) 9.21 0.001688 0.011951
GO:2000738 positive regulation of stem cell differentiation 50.0% (1/2) 9.61 0.001279 0.011966
GO:0048738 cardiac muscle tissue development 50.0% (1/2) 9.93 0.001023 0.012184
GO:0014706 striated muscle tissue development 50.0% (1/2) 9.3 0.001586 0.012218
GO:0051155 positive regulation of striated muscle cell differentiation 50.0% (1/2) 9.3 0.001586 0.012218
GO:0006977 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest 50.0% (1/2) 9.86 0.001074 0.012237
GO:0110020 regulation of actomyosin structure organization 50.0% (1/2) 9.25 0.001637 0.012252
GO:1903684 regulation of border follicle cell migration 50.0% (1/2) 9.45 0.001432 0.012508
GO:1903688 positive regulation of border follicle cell migration 50.0% (1/2) 9.45 0.001432 0.012508
GO:2000765 regulation of cytoplasmic translation 50.0% (1/2) 9.4 0.001483 0.012536
GO:0030330 DNA damage response, signal transduction by p53 class mediator 50.0% (1/2) 9.35 0.001534 0.012563
GO:0035925 mRNA 3'-UTR AU-rich region binding 50.0% (1/2) 8.9 0.002097 0.012776
GO:0042772 DNA damage response, signal transduction resulting in transcription 50.0% (1/2) 10.93 0.000512 0.014893
GO:0045663 positive regulation of myoblast differentiation 50.0% (1/2) 10.93 0.000512 0.014893
GO:1902809 regulation of skeletal muscle fiber differentiation 50.0% (1/2) 10.93 0.000512 0.014893
GO:2000766 negative regulation of cytoplasmic translation 50.0% (1/2) 10.93 0.000512 0.014893
GO:2001016 positive regulation of skeletal muscle cell differentiation 50.0% (1/2) 10.93 0.000512 0.014893
GO:0009952 anterior/posterior pattern specification 50.0% (1/2) 8.61 0.002557 0.015224
GO:0010634 positive regulation of epithelial cell migration 50.0% (1/2) 8.04 0.003783 0.015248
GO:1902905 positive regulation of supramolecular fiber organization 50.0% (1/2) 8.04 0.003783 0.015248
GO:0048027 mRNA 5'-UTR binding 50.0% (1/2) 8.23 0.003323 0.015275
GO:0060562 epithelial tube morphogenesis 50.0% (1/2) 8.23 0.003323 0.015275
GO:0030371 translation repressor activity 50.0% (1/2) 8.1 0.00363 0.015338
GO:0036002 pre-mRNA binding 50.0% (1/2) 8.1 0.00363 0.015338
GO:0051147 regulation of muscle cell differentiation 50.0% (1/2) 8.28 0.003221 0.015343
GO:1902807 negative regulation of cell cycle G1/S phase transition 50.0% (1/2) 8.28 0.003221 0.015343
GO:0009692 ethylene metabolic process 50.0% (1/2) 8.35 0.003068 0.015456
GO:0009693 ethylene biosynthetic process 50.0% (1/2) 8.35 0.003068 0.015456
GO:0043449 cellular alkene metabolic process 50.0% (1/2) 8.35 0.003068 0.015456
GO:0043450 alkene biosynthetic process 50.0% (1/2) 8.35 0.003068 0.015456
GO:0044773 mitotic DNA damage checkpoint signaling 50.0% (1/2) 8.06 0.003732 0.015519
GO:2000736 regulation of stem cell differentiation 50.0% (1/2) 8.13 0.003579 0.015626
GO:0060537 muscle tissue development 50.0% (1/2) 8.45 0.002863 0.015629
GO:0072331 signal transduction by p53 class mediator 50.0% (1/2) 8.45 0.002863 0.015629
GO:1900673 olefin metabolic process 50.0% (1/2) 8.15 0.003527 0.015664
GO:1900674 olefin biosynthetic process 50.0% (1/2) 8.15 0.003527 0.015664
GO:2000134 negative regulation of G1/S transition of mitotic cell cycle 50.0% (1/2) 8.3 0.00317 0.01567
GO:0051153 regulation of striated muscle cell differentiation 50.0% (1/2) 8.53 0.00271 0.015778
GO:0043186 P granule 50.0% (1/2) 8.47 0.002812 0.016017
GO:0000381 regulation of alternative mRNA splicing, via spliceosome 50.0% (1/2) 7.93 0.004089 0.016233
GO:0050779 RNA destabilization 50.0% (1/2) 7.81 0.004447 0.016884
GO:0061157 mRNA destabilization 50.0% (1/2) 7.81 0.004447 0.016884
GO:0044774 mitotic DNA integrity checkpoint signaling 50.0% (1/2) 7.85 0.004344 0.016989
GO:0051495 positive regulation of cytoskeleton organization 50.0% (1/2) 7.76 0.0046 0.017216
GO:0000077 DNA damage checkpoint signaling 50.0% (1/2) 7.63 0.005059 0.018669
GO:0010632 regulation of epithelial cell migration 50.0% (1/2) 7.55 0.005314 0.019338
GO:2000045 regulation of G1/S transition of mitotic cell cycle 50.0% (1/2) 7.53 0.005416 0.01944
GO:0042770 signal transduction in response to DNA damage 50.0% (1/2) 7.47 0.00562 0.0199
GO:0003730 mRNA 3'-UTR binding 50.0% (1/2) 7.31 0.006284 0.021381
GO:1902806 regulation of cell cycle G1/S phase transition 50.0% (1/2) 7.32 0.006233 0.021486
GO:0031570 DNA integrity checkpoint signaling 50.0% (1/2) 7.34 0.006182 0.021595
GO:0035239 tube morphogenesis 50.0% (1/2) 7.17 0.006947 0.023038
GO:0061014 positive regulation of mRNA catabolic process 50.0% (1/2) 7.17 0.006947 0.023038
GO:0007093 mitotic cell cycle checkpoint signaling 50.0% (1/2) 7.08 0.007355 0.024086
GO:0002009 morphogenesis of an epithelium 50.0% (1/2) 6.85 0.008629 0.02791
GO:0032956 regulation of actin cytoskeleton organization 50.0% (1/2) 6.71 0.009545 0.028746
GO:2000147 positive regulation of cell motility 50.0% (1/2) 6.71 0.009545 0.028746
GO:0000075 cell cycle checkpoint signaling 50.0% (1/2) 6.77 0.009138 0.028845
GO:1901991 negative regulation of mitotic cell cycle phase transition 50.0% (1/2) 6.77 0.009138 0.028845
GO:0048024 regulation of mRNA splicing, via spliceosome 50.0% (1/2) 6.72 0.009494 0.029265
GO:0030335 positive regulation of cell migration 50.0% (1/2) 6.72 0.009444 0.029455
GO:0043488 regulation of mRNA stability 50.0% (1/2) 6.58 0.010411 0.029648
GO:0032970 regulation of actin filament-based process 50.0% (1/2) 6.59 0.01036 0.029828
GO:0040017 positive regulation of locomotion 50.0% (1/2) 6.55 0.010614 0.029903
GO:0045930 negative regulation of mitotic cell cycle 50.0% (1/2) 6.6 0.010309 0.030011
GO:1902903 regulation of supramolecular fiber organization 50.0% (1/2) 6.6 0.010309 0.030011
GO:0003228 atrial cardiac muscle tissue development 50.0% (1/2) 11.08 0.00046 0.03016
GO:0006978 DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator 50.0% (1/2) 11.08 0.00046 0.03016
GO:0048729 tissue morphogenesis 50.0% (1/2) 6.6 0.010258 0.030541
GO:1903313 positive regulation of mRNA metabolic process 50.0% (1/2) 6.51 0.010971 0.030578
GO:1901988 negative regulation of cell cycle phase transition 50.0% (1/2) 6.47 0.011225 0.030958
GO:0050684 regulation of mRNA processing 50.0% (1/2) 6.38 0.011937 0.030966
GO:0061013 regulation of mRNA catabolic process 50.0% (1/2) 6.38 0.011937 0.030966
GO:0017148 negative regulation of translation 50.0% (1/2) 6.42 0.011632 0.031098
GO:0120255 olefinic compound biosynthetic process 50.0% (1/2) 6.4 0.011785 0.031188
GO:0045727 positive regulation of translation 50.0% (1/2) 6.43 0.011581 0.031281
GO:0034249 negative regulation of cellular amide metabolic process 50.0% (1/2) 6.35 0.012192 0.031316
GO:0043487 regulation of RNA stability 50.0% (1/2) 6.43 0.01153 0.031468
GO:0043484 regulation of RNA splicing 50.0% (1/2) 6.31 0.012548 0.031917
GO:0034250 positive regulation of cellular amide metabolic process 50.0% (1/2) 6.24 0.013158 0.033147
GO:2000113 negative regulation of cellular macromolecule biosynthetic process 50.0% (1/2) 6.11 0.014377 0.035536
GO:0045182 translation regulator activity 50.0% (1/2) 6.12 0.014326 0.035748
GO:0010948 negative regulation of cell cycle process 50.0% (1/2) 6.09 0.014631 0.035826
GO:0030334 regulation of cell migration 50.0% (1/2) 6.03 0.015291 0.037095
GO:2000145 regulation of cell motility 50.0% (1/2) 6.0 0.015596 0.037487
GO:0008285 negative regulation of cell population proliferation 50.0% (1/2) 5.92 0.016459 0.039202
GO:0051493 regulation of cytoskeleton organization 50.0% (1/2) 5.9 0.016662 0.039328
GO:0045786 negative regulation of cell cycle 50.0% (1/2) 5.88 0.016966 0.039689
GO:0048598 embryonic morphogenesis 50.0% (1/2) 5.84 0.017372 0.039925
GO:1901990 regulation of mitotic cell cycle phase transition 50.0% (1/2) 5.85 0.017321 0.040161
GO:0040012 regulation of locomotion 50.0% (1/2) 5.68 0.01945 0.043556
GO:0120254 olefinic compound metabolic process 50.0% (1/2) 5.7 0.019146 0.04362
GO:0010638 positive regulation of organelle organization 50.0% (1/2) 5.68 0.019349 0.043702
GO:0036464 cytoplasmic ribonucleoprotein granule 50.0% (1/2) 5.61 0.020312 0.045098
GO:0035770 ribonucleoprotein granule 50.0% (1/2) 5.59 0.020615 0.045388
GO:1903311 regulation of mRNA metabolic process 50.0% (1/2) 5.58 0.020818 0.045452
GO:0045597 positive regulation of cell differentiation 50.0% (1/2) 5.55 0.021274 0.046063
GO:1901987 regulation of cell cycle phase transition 50.0% (1/2) 5.49 0.022134 0.047533
GO:0031331 positive regulation of cellular catabolic process 50.0% (1/2) 5.46 0.022589 0.048117
Enriched Clades (corrected p-value < 0.05) (download table)
Clade % in cluster Enrichment log2 p-value Corrected p-value Gene Family Method
No enriched Clades found
Similar Clusters (download table)
Species Clustering Method Target Jaccard index Gene Family Method (for comparison) Actions
No similar clusters found
Sequences (2) (download table)

InterPro Domains

GO Terms

Family Terms